6Aziz MA, Wright A, Laszlo A, et al. Epidemiology of antituberculosis drug resistance (the Global Project on Antituberculosis Drug Resistance Surveillance) : an updated analysis. Lancet, 2006,368: 2142-2154.
7Espinal M, Raviglione MC. From threat to reality: the real face of muhidrug-resistant tuberculosis. Am J Respir Crit Care Med, 2008,178:216-217.
8Center for Disease Control and Prevention (CDC). Extensively drug-resistant tuberculosis--United States, 1993-2006. MMWR Morb Mortal Wkly Rep, 2007,56:250-253.
9Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet, 2006,368 : 1575-1580.
10Masjedi MR, Tabarsi P, Chitsaz E, et al. Outcome of treatment of MDR-TB patients with standardised regimens,Iran,2002-2006. Int J Tuberc Lung Dis, 2008,12:750-755.
9Falzon D, Jaramillo E, Schilnemann HJ, et al. WHO guidelinesfor the programmatic management of drug-resistant tuberculosis:2011update[J]. Eur Respir J,2011,38:516-528.
